Identification of causative gene for type 2 diabetes in SMXA-5 mouse feeding a high fat diet.

鉴定喂养高脂肪饮食的 SMXA-5 小鼠 2 型糖尿病致病基因。

基本信息

项目摘要

The SMXA-5 mouse is one of the 26 SMXA recombinant inbred (RI) substrains that have been established from nondiabetic SMIJ and A/J strains. This mouse is a model for polygenic type 2 diabetes characterized by both moderate impairment of glucose tolerance and mild hyperinsulinemia. To dissect A/J-derived diabetogenic loci of SMXA-5 contributing to diabetes-related traits such as impaired glucose tolerance, hyperglycemia, hyperinsulinemia, and obesity, we attempted to analyze the quantitative trait loci (QTL) in (SM/J x SAM-5)F2 intercross mice fed a high-fat diet. A major QTL for body mass index, nonfasting blood glucose concentration, and glucose tolerance was mapped on Chr 2. This locus existed near D2Mit15, with the highest logarithm of odds (LOD) score, 12.5, for glucose concentration being recorded at 120 min in an intraperitoneal glucose tolerance test (IPGTT). We designated this QTL as t2dm2sa, for type 2 diabetes mellitus 2 in the SMXA RI strains. SM.A-t2dm2sa, a congenic strain that introgressed the A/J-derived t2dm2sa region into SM/J, exhibited overt impaired glucose tolerance and mild hyperinsulinemia under a high-fat diet. These results suggested that latent diabetogenic genes exist in the genomes of nondiabetic AM and SM/J mice, and that interaction between t2dm2sa and an unknown SM/J-derived locus except where t2dm2sa exists, elicits impaired glucose tolerance in SMXA-5 and SM.A-t2dm2sa mice. The dissection of these diabetogenic genes that have epistatic effects will contribute to the elucidation of the complex mechanisms underlying human type 2 diabetes.
SMXA-5小鼠是从非糖尿病SMIJ和A/J品系建立的26个SMXA重组近交(RI)亚系之一。该小鼠是多基因2型糖尿病的模型,其特征在于葡萄糖耐量的中度损害和轻度高胰岛素血症。为了分析SMXA-5中A/J基因的致糖尿病基因座对糖耐量异常、高血糖、高胰岛素血症和肥胖等糖尿病相关性状的影响,我们试图分析高脂饲料喂养的(SM/J x SAM-5)F2杂交小鼠的数量性状基因座(QTL)。一个主要的QTL的体重指数,非空腹血糖浓度,和葡萄糖耐量被定位在第2章。该位点存在于D2 Mit 15附近,在腹膜内葡萄糖耐量试验(IPGTT)中,在120 min时记录到葡萄糖浓度的最高对数比值(LOD)评分为12.5。我们将SMXA RI菌株中2型糖尿病的该QTL命名为t2 dm 2sa。SM. A-t2 dm 2sa是一个将A/J衍生的t2 dm 2sa区域渗入SM/J的同源菌株,在高脂饮食下表现出明显的糖耐量受损和轻度高胰岛素血症。这些结果表明,潜在的致糖尿病基因存在于非糖尿病AM和SM/J小鼠的基因组中,并且t2 dm 2sa与除了t2 dm 2sa存在之外的未知SM/J衍生位点之间的相互作用导致SMXA-5和SM. A-t2 dm 2sa小鼠的糖耐量受损。这些具有上位效应的致糖尿病基因的解剖将有助于阐明人类2型糖尿病的复杂机制。

项目成果

期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Changes in catecholamine metabolism by ascorbic acid deficiency in spontaneously hypertensive rats unable to synthesize ascorbic acid.
无法合成抗坏血酸的自发性高血压大鼠抗坏血酸缺乏导致儿茶酚胺代谢的变化。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kawai;K.
  • 通讯作者:
    K.
Quantitative trait locus analysis of serum insulin, triglyceride, total cholesterol and phospholipid levels in the (SM/J x A/J)F2 mice
  • DOI:
    10.1538/expanim.52.37
  • 发表时间:
    2003-01-01
  • 期刊:
  • 影响因子:
    2.4
  • 作者:
    Anunciado, RVP;Nishimura, M;Namikawa, T
  • 通讯作者:
    Namikawa, T
Combinations of non-diabetic parental genomes elicit impaired glucose tolerance in mouse SMXA RI strains.
非糖尿病亲本基因组的组合会导致小鼠 SMXA RI 品系的葡萄糖耐量受损。
  • DOI:
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Kobayashi;M.
  • 通讯作者:
    M.
リコンビナント・インブレッド系統マウスを用いた2型糖尿病原因遺伝子の探索
使用重组近交系小鼠品系寻找 2 型糖尿病致病基因
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    都築 巧;伏木 亨;小林美里
  • 通讯作者:
    小林美里
Characteristics of ascorbic acid metabolism in the scurvy-prone spontaneously hypertensive rat, SHR-od.
易患坏血病的自发性高血压大鼠 SHR-od 的抗坏血酸代谢特征。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HORIO Fumihiko其他文献

HORIO Fumihiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HORIO Fumihiko', 18)}}的其他基金

Identification of diabetogenic and obesity genes by using nucleotides sequence variations between SM/J and A/J mice.
利用 SM/J 和 A/J 小鼠之间的核苷酸序列变异鉴定糖尿病和肥胖基因。
  • 批准号:
    24380068
  • 财政年份:
    2012
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Pioneer study on the protective effect of ascorbic acid on barrier function of gastrointestinal tract
抗坏血酸对胃肠道屏障功能保护作用的开创性研究
  • 批准号:
    22658042
  • 财政年份:
    2010
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Identification of the diabetogenic gene and its related genes of high fat diet-induced diabetes by using novel mouse model
利用新型小鼠模型鉴定高脂饮食诱发糖尿病的致糖尿病基因及其相关基因
  • 批准号:
    21380079
  • 财政年份:
    2009
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The analysis of inflammation-like response caused by ascorbic acid deficiency in ODS rats unable to synthesize ascorbic acid.
无法合成抗坏血酸的ODS大鼠抗坏血酸缺乏引起的炎症样反应分析。
  • 批准号:
    13660121
  • 财政年份:
    2001
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of a novel strain of spontaneously hypertensive rat with a defect of ascorbic acid biosynthesis, and the effect of ascorbic acid deficiency on the hypertension
抗坏血酸生物合成缺陷型自发性高血压大鼠新品系的建立及抗坏血酸缺乏对高血压的影响
  • 批准号:
    11660125
  • 财政年份:
    1999
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic analysis of diabetes in SMXA recombinant inbred strain of mice.
SMXA重组近交系小鼠糖尿病的遗传分析。
  • 批准号:
    11556024
  • 财政年份:
    1999
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Regulation of acute phase protein gene expression by ascorbic acid.
抗坏血酸对急性期蛋白基因表达的调节。
  • 批准号:
    09660134
  • 财政年份:
    1997
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The roles of bilirubin and ascorbic acid as physiological antioxidant against oxidative stress.
胆红素和抗坏血酸作为生理抗氧化剂对抗氧化应激的作用。
  • 批准号:
    07660160
  • 财政年份:
    1995
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regulation of apolipoprotein A-I gene expression by ascorbic acid in scurvy-prone ODS-od/od rats.
抗坏血酸对易患坏血病的 ODS-od/od 大鼠中载脂蛋白 A-I 基因表达的调节。
  • 批准号:
    05660136
  • 财政年份:
    1993
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases
Cela2a(一种健康和疾病代谢综合征的新型疾病基因)的表征
  • 批准号:
    10681049
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
An interrogation of synaptic dysfunctions arising from human cognitive disease gene mutations using opto-physiological and neurochemical strategies.
使用光生理学和神经化学策略对人类认知疾病基因突变引起的突触功能障碍进行研究。
  • 批准号:
    MR/X02170X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Research Grant
Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1
人类新型冠状动脉疾病基因SVEP1的机制研究
  • 批准号:
    10590681
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
An integrative approach to disease gene discovery combining genetic variation, gene expression, and epigenetics.
结合遗传变异、基因表达和表观遗传学的疾病基因发现的综合方法。
  • 批准号:
    10581608
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
An integrative approach to disease gene discovery combining genetic variation, gene expression, and epigenetics.
结合遗传变异、基因表达和表观遗传学的疾病基因发现的综合方法。
  • 批准号:
    10349878
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1
人类新型冠状动脉疾病基因SVEP1的机制研究
  • 批准号:
    10446520
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
Mitochondrial disease gene analysis focusing on RNA splicing abnormalities
关注RNA剪接异常的线粒体疾病基因分析
  • 批准号:
    22K15950
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
TCF21 is a causal coronary artery disease gene that modulates coronary smooth muscle phenotypic transition via epigenetic mechanisms
TCF21 是一种致病性冠状动脉疾病基因,可通过表观遗传机制调节冠状动脉平滑肌表型转变
  • 批准号:
    10536419
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
TCF21 is a causal coronary artery disease gene that modulates coronary smooth muscle phenotypic transition via epigenetic mechanisms
TCF21 是一种致病性冠状动脉疾病基因,可通过表观遗传机制调节冠状动脉平滑肌表型转变
  • 批准号:
    10874376
  • 财政年份:
    2022
  • 资助金额:
    $ 2.43万
  • 项目类别:
Methods for including the X chromosome in genetic association studies to advance disease gene mapping
将 X 染色体纳入遗传关联研究以推进疾病基因图谱的方法
  • 批准号:
    452392
  • 财政年份:
    2021
  • 资助金额:
    $ 2.43万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了